Type 2 Diabetes
Conditions
Keywords
type 2 diabetes, analogies, M2-PRIME, Consultation module
Brief summary
The goal of this retrospective interventional study is to learn whether a new consultation approach called M2-PRIME can help improve blood sugar control in people with type 2 diabetes who use insulin and have high blood sugar levels (HbA1c more than 8.5%). The main questions are: 1. Does using M2-PRIME during consultations help lower HbA1c (3-month average blood sugar level)? 2. Does using M2-PRIME help lower fasting blood sugar (FBS, morning blood sugar)? In this study, participants received their regular diabetes care at the Self-Monitoring of Blood Glucose (SMBG) clinic, which runs once a week. Two primary healthcare providers (PHPs) trained in the M2-PRIME framework provided the consultations. During each visit, PHPs used M2-PRIME to: 1. Build rapport and review the participant's health and lifestyle, 2. Give simple advice about food, activity, and insulin use, 3. Use the "Garbage and Lorry" analogy to explain how the body handles sugar, 4. Educate regarding insulin self-adjustment and monitoring 5\. Adjust insulin doses when needed Each participant had three consultations over six months. Their HbA1c and fasting blood glucose were measured at the start and after six months to see if their blood sugar control improved.
Detailed description
This study is designed to evaluate the effectiveness of a novel analogy-based consultation framework, called M2-PRIME (The Metaphoric Medicine Practical Roadmap for Insulin Management Essentials ), in improving glycaemic control among insulin-treated type 2 diabetes mellitus (T2DM) patients. The M2-PRIME framework aims to simplify complex diabetes concepts using metaphors and analogies. Its core analogy, the "Garbage and Lorry" model, describes blood sugar as "garbage" that accumulates in the bloodstream, while insulin acts as a "lorry" that carries the sugar into the body's cells, represented as the "factory." The framework is intended to improve understanding, adherence, and motivation among people with T2DM through simplified and unified communication. This will be a retrospective, single-group pre-post interventional study conducted at a government primary care Self-Monitoring of Blood Glucose (SMBG) clinic in Klinik Kesihatan Senawang, Negeri Sembilan, Malaysia. The clinic runs once a week and is managed by two trained primary healthcare providers (PHPs). Participants will include adults with insulin-treated T2DM and poor glycaemic control (HbA1c \> 8.5%). All participants will have received standard diabetes care at the SMBG clinic, with M2-PRIME introduced as part of routine service improvement. Each participant will have received up to three structured M2-PRIME consultations over six months. Each consultation will include: 1. Building rapport and reviewing medical and lifestyle history, 2. Providing tailored education on diet, physical activity, and medication adherence, 3. Using the "Garbage and Lorry" analogy to explain how insulin helps lower blood sugar 4. Adjusting insulin doses and problem-solving based on self-monitoring results. The primary outcomes will be changes in HbA1c (%) and fasting blood sugar (FBS, mmol/L) between baseline and six months after the final consultation. Outcome data will be collected from participants who completed follow-up, and will be analyzed using paired-samples statistical tests. This study has received approval from the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia (NMRR ID-: 24-00725-QIL, Ref: 24-00725-QIL). Because it involves retrospective analysis of anonymized clinical data from patients who had already received standard care, the requirement for individual informed consent has been waived in accordance with the Declaration of Helsinki (2013) and Malaysian Good Clinical Practice guidelines.
Interventions
Participants received consultations delivered using the M2-PRIME framework, which applies analogy-based education (e.g., the "Garbage and Lorry" model) to improve understanding of diabetes and insulin use.
Sponsors
Study design
Eligibility
Inclusion criteria
* Established T2DM patients, already on insulin therapy regardless of the type of insulin or regime or duration of treatment * HbA1c at referral more than 8.5% * Already seen by diabetic educator or dietician prior to referral
Exclusion criteria
* Pregnant or found to be pregnant during follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c | 6 months | HbA1c (%) at 6 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fasting Blood Sugar | 6 months | Fasting Blood Sugar (FBS) (mmol/L) in 6 months |
Countries
Malaysia
Contacts
Ministry of Health, Malaysia
Participant flow
Recruitment details
Participants were identified through routine referrals to the Self-Monitoring of Blood Glucose (SMBG) clinic at Klinik Kesihatan Senawang. All eligible adults with insulin-treated type 2 diabetes mellitus and HbA1c greater than 8.5% during the study period were enrolled as part of standard clinical care.
Pre-assignment details
This study involved a retrospective review of anonymized clinical records of patients who had already received standard care under the SMBG clinic. No randomization or allocation to study groups occurred. The M2-PRIME consultation framework was implemented as part of routine service improvement prior to data extraction. Participants were included in the analysis if they completed at least three consultation sessions with available baseline and follow-up HbA1c data.
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 57.2 Years STANDARD_DEVIATION 10.7 |
| Baseline fasting blood glucose | 12.54 mmol/L STANDARD_DEVIATION 6.32 |
| Baseline HbA1c | 11.88 Percent STANDARD_DEVIATION 1.84 |
| Sex: Female, Male Female | 51 Participants |
| Sex: Female, Male Male | 38 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 89 |
| other Total, other adverse events | 0 / 89 |
| serious Total, serious adverse events | 0 / 89 |